Atlas Trials

Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide

Clinical trial NCT02966301 · COMPLETED

Trial details

NCT number
NCT02966301
Sponsor
Medsenic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Graft-Versus-Host DiseaseImmune System Diseases
Start date
2016-12-01
Primary completion
2020-06-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.